# Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study

> **NCT02293746** · PHASE4 · COMPLETED · sponsor: **Inspire Medical Systems, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** Inspire® Upper Airway Stimulation (UAS) System

## Key facts

- **NCT ID:** NCT02293746
- **Lead sponsor:** Inspire Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-12-11
- **Final completion:** 2017-01-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293746, "Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02293746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*